Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Schutzer, William E ^a   Mader, Scott L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENYLATE CYCLASE; ADRENALIN; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; NITRIC OXIDE; NORADRENALIN; PHOSPHODIESTERASE; RETINA S ANTIGEN; SCAFFOLD PROTEIN;

ADRENERGIC SYSTEM; AGE DISTRIBUTION; AGING; ARTERIAL INSUFFICIENCY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CELL LEVEL; CHEMICAL ANALYSIS; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME SYNTHESIS; HUMAN; HYPERTENSION; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; NONHUMAN; ORTHOSTATIC HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULARIZATION; VASODILATATION;

EID: 84868294994     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/915057     Document Type: Review

References (111)

1. Humes K., The population 65 years and older: aging in America. US Department of Comerce, Economics and Statistics Administration. The Book of the States 2005 2005 The Council of State Governents 464 468
2. Lakatta E. G., Wang M., Najjar S. S., Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Medical Clinics of North America 2009 93 3 583 604 2-s2.0-65449164914 10.1016/j.mcna.2009.02.008
3. Lim M. A., Townsend R. R., Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. Clinics in Geriatric Medicine 2009 25 2 191 205 2-s2.0-67449084270 10.1016/j.cger.2009.01.001
4. Herrera M. D., Mingorance C., Rodríguez-Rodríguez R., Alvarez de Sotomayor M., Endothelial dysfunction and aging: an update. Ageing Research Reviews 2010 9 2 142 152 2-s2.0-77949266553 10.1016/j.arr.2009.07.002
5. Orlandi A., Bochaton-Piallat M. L., Gabbiani G., Spagnoli L. G., Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis 2006 188 2 221 230 2-s2.0-33748082993 10.1016/j. atherosclerosis.2006.01.018 (Pubitemid 44301147)
6. Dessy C., Balligand J. L., Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Advances in Pharmacology 2010 59 C 135 163 2-s2.0-77957372042 10.1016/S1054-3589(10)59005-7
7. Chapman J., Schutzer W. E., Watts V. J., Mader S. L., Impaired cholera toxin relaxation with age in rat aorta. Journals of GerontologySeries A 1999 54 4 B154 B159 2-s2.0-0032935418 (Pubitemid 29183857)
8. Kobilka B. K., Structural insights into adrenergic receptor function and pharmacology. Trends in Pharmacological Sciences 2011 32 4 213 218
9. Fleg J. L., Aronow W. S., Frishman W. H., Cardiovascular drug therapy in the elderly: benefits and challenges. Nature Reviews Cardiology 2011 8 1 13 28 2-s2.0-78650513278 10.1038/nrcardio.2010.162
10. Lefkowitz R. J., Seven transmembrane receptors: something old, something new. Acta Physiologica 2007 190 1 9 19 2-s2.0-34147137118 10.1111/j.1365-201X. 2007.01693.x (Pubitemid 46570176)
11. Gaballa M. A., Eckhart A. D., Koch W. J., Goldman S., Vascular β -adrenergic receptor adenylyl cyclase system in maturation and aging. Journal of Molecular and Cellular Cardiology 2000 32 9 1745 1755 2-s2.0-0033804613 10.1006/jmcc.2000.1210
12. Schutzer W. E., Xue H., Reed J. F., Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteins. Journals of GerontologySeries A 2006 61 9 899 906 (Pubitemid 44413928)
13. Walsh M. P., Regulation of vascular smooth muscle tone. Canadian Journal of Physiology and Pharmacology 1994 72 8 919 936 2-s2.0-0028104901 (Pubitemid 24336849)
14. Hathaway D. R., March K. L., Lash J. A., Adam L. P., Wilensky R. L., Vascular smooth muscle. A review of the molecular basis of contractility. Circulation 1991 83 2 382 390 2-s2.0-0026069167
15. Somlyo A. P., Wu X., Walker L. A., Somlyo A. V., Pharmacomechanical coupling: the role of calcium, G-proteins, kinases, and phosphatases. Reviews of Physiology, Biochemistry and Pharmacology 1999 134 201 234 2-s2.0-0032620047
16. Ross E. M., Hardman J. G., Pharmacodynamics. Goodman and Gilman's The Pharmacological Basis of Therapeutics 1996 New York, NY, USA McGraw-Hill 29 42
17. Michel J. J. C., Scott J. D., AKAP-mediated signal transduction. Annual Review of Pharmacology and Toxicology 2002 42 235 257 2-s2.0-0036174860 10.1146/annurev.pharmtox.42.083101.135801 (Pubitemid 34160527)
18. Benovic J. L., Strasser R. H., Caron M. G., Lefkowitz R. J., β -adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proceedings of the National Academy of Sciences of the United States of America 1986 83 9 2797 2801 2-s2.0-0344812247 (Pubitemid 16041750)
19. Miller W. E., Lefkowitz R. J., Expanding roles for β -arrestins as scaffolds and adaptors in G protein-coupled receptor signaling and trafficking. Current Opinion in Cell Biology 2001 139 145 (Pubitemid 32209213)
20. Guimarães S., Moura D., Vascular adenoreceptors: an update. Pharmacological Reviews 2001 53 2 319 356 2-s2.0-0034999544
21. Hurley J. H., Structure, mechanism, and regulation of mammalian adenylyl cyclase. Journal of Biological Chemistry 1999 274 12 7599 7602 2-s2.0-0033583237 10.1074/jbc.274.12.7599 (Pubitemid 29144215)
22. Sunahara R. K., Dessauer C. W., Gilman A. G., Complexity and diversity of mammalian adenylyl cyclases. Annual Review of Pharmacology and Toxicology 1996 36 461 480 2-s2.0-0029992477 (Pubitemid 26168706)
23. Pitcher J. A., Freedman N. J., Lefkowitz R. J., G protein-coupled receptor kinases. Annual Review of Biochemistry 1998 67 653 692 2-s2.0-0031692337 10.1146/annurev.biochem.67.1.653 (Pubitemid 28411141)
24. Krupnick J. G., Benovic J. L., The role of receptor kinases and arrestins in G-protein-coupled receptor regulation. Annual Review of Pharmacology and Toxicology 1998 38 289 319 2-s2.0-0031747997 (Pubitemid 28231497)
25. Colledge M., Scott J. D., AKAPs: from structure to function. Trends in Cell Biology 1999 9 6 216 221 2-s2.0-0033021636 10.1016/S0962-8924(99)01558-5 (Pubitemid 29244132)
26. Zheng B., Ma Y. C., Ostrom R. S., Lavoie C., Gill G. N., Insel P. A., Huang X. Y., Farquhar M. G., RGS-PX1, a GAP for G α s and sorting nexin in vesicular trafficking. Science 2001 294 5548 1939 1942 2-s2.0-0035976614 10.1126/science.1064757 (Pubitemid 33101593)
27. Fleisch J. H., Further studies on the effect of ageing on β -adrenoceptor activity of rat aorta. The British Journal of Pharmacology 1971 42 2 311 313 2-s2.0-0015080492
28. Fleisch J. H., Maling H. M., Brodie B. B., Beta receptor activity in aorta: variations with age and species. Circulation Research 1970 26 2 151 162 2-s2.0-0014736511
29. Fleisch J. H., Age-related decrease in beta adrenoceptor activity of the cardiovascular system. Trends in Pharmacological Sciences 1981 2 C 337 339 2-s2.0-0000897158
30. Rosenbaum D. M., Zhang C., Lyons J. A., Structure and function of an irreversible agonist-beta(2) adrenoceptor complex. Nature 2011 469 7329 236 240
31. Begonha R., Moura D., Guimaraes S., Vascular β -adrenoceptor- mediated vasorelaxation and tone of the tissues of the canine artery. Journal of Pharmacy and Pharmacology 1995 47 6 510 513 2-s2.0-0029010614
32. Osswald W., Guimarães S., Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Reviews of Physiology Biochemistry and Pharmacology 1983 96 53 122 2-s2.0-0020650927
33. Chruscinski A. J., Rohrer D. K., Schauble E., Desai K. H., Bernstein D., Kobilka B. K., Targeted disruption of the β 2 adrenergic receptor gene. Journal of Biological Chemistry 1999 274 24 16694 16700 2-s2.0-0033546002 10.1074/jbc.274.24.16694 (Pubitemid 29275114)
34. Rohrer D. K., Chruscinski A., Schauble E. H., Bernstein D., Kobilka B. K., Cardiovascular and metabolic alterations in mice lacking both β 1- and β 2-adrenergic receptors. Journal of Biological Chemistry 1999 274 24 16701 16708 2-s2.0-0033546313 10.1074/jbc.274.24.16701 (Pubitemid 29275115)
35. 2-adrenergic signal transduction. Circulation Research 1999 85 11 1092 1100 2-s2.0-0033607558
36. 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. Journal of Biological Chemistry 1995 270 30 17953 17961 2-s2.0-0029057061 10.1074/jbc.270.30.17953
37. Hausdorff W. P., Bouvier M., O'Dowd B. F., Irons G. P., Caron M. G., Lefkowitz R. J., Phosphorylation sites on two domains of the β 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. Journal of Biological Chemistry 1989 264 21 12657 12665 2-s2.0-0024397065 (Pubitemid 19191160)
38. Daaka Y., Luttrell L. M., Lefkowitz R. J., Switching of the coupling of the β 2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997 390 6655 88 91 2-s2.0-0030613761 10.1038/36362 (Pubitemid 27494762)
39. Xiao R. P., Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Science's STKE 2001 2001 104 RE15 2-s2.0-17144439929
40. Lefkowitz R. J., Pierce K. L., Luttrell L. M., Dancing with different partners: protein kinase A phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Molecular Pharmacology 2002 62 5 971 974 2-s2.0-0036839745 10.1124/mol.62.5.971 (Pubitemid 35222487)
41. Tepe N. M., Liggett S. B., Functional receptor coupling to G(i) is a mechanism of agonist-promoted desensitization of the β 2-adrenergic receptor. Journal of Receptor and Signal Transduction Research 2000 20 1 75 85 2-s2.0-0034093205 (Pubitemid 30123166)
42. 2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America 1993 90 8 3665 3669 2-s2.0-0027418423 (Pubitemid 23111428)
43. Xiao R. P., Avdonin P., Zhou Y. Y., Cheng H., Akhter S. A., Eschenhagen T., Lefkowitz R. J., Koch W. J., Lakatta E. G., Coupling of β 2-adrenoceptor to G(i) proteins and its physiological relevance in murine cardiac myocytes. Circulation Research 1999 84 1 43 52 2-s2.0-0033593121 (Pubitemid 29074879)
44. Chen Z., Miao G., Liu M., Hao G., Liu Y., Fang X., Zhang Z., Lu L., Zhang J., Zhang L., Age-related up-regulation of β 3-adrenergic receptor in heart-failure rats. Journal of Receptors and Signal Transduction 2010 30 4 227 233 2-s2.0-77954528312 10.3109/10799891003801918
45. Gurdal H., Friedman E., Johnson M., β -Adrenoceptor-G(α s) coupling decreases with age in rat aorta. Molecular Pharmacology 1995 47 4 772 778 2-s2.0-0028986867
46. Mercier J. F., Salahpour A., Angers S., Breit A., Bouvier M., Quantitative assessment of β 1- and β 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. Journal of Biological Chemistry 2002 277 47 44925 44931 2-s2.0-0037160105 10.1074/jbc.M205767200 (Pubitemid 36159089)
47. Lavoie C., Mercier J. F., Salahpour A., Umapathy D., Breit A., Villeneuve L. R., Zhu W. Z., Xiao R. P., Lakatta E. G., Bouvier M., Hébertl T. E., β 1/ β 2-adrenergic receptor heterodimerization regulates β 2-adrenergic receptor internalization and ERK signaling efficacy. Journal of Biological Chemistry 2002 277 38 35402 35410 2-s2.0-0037144542 10.1074/jbc.M204163200
48. Zhu W. Z., Chakir K., Zhang S., Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circulation Research 2005 97 3 244 251 (Pubitemid 41105450)
49. Ianoul A., Grant D. D., Rouleau Y., Bani-Yaghoub M., Johnston L. J., Pezacki J. P., Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes. Nature Chemical Biology 2005 1 4 196 202 2-s2.0-29244466321 10.1038/nchembio726
50. LaRocca T. J., Schwarzkopf M., Altman P., Beta2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. Journal of Cardiovascular Pharmacology 2011 56 5 548 559
51. Schutzer W. E., Reed J. F., Bliziotes M., Mader S. L., Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. The American Journal of Physiology 2001 280 3 R897 R903 2-s2.0-0035002227
52. Johnson M. D., Zhou Y., Friedman E., Roberts J., Expression of G protein α subunits in the aging cardiovascular system. Journals of GerontologySeries A 1995 50 1 B14 B19 2-s2.0-0028910874
53. Kazanietz M. G., Enero M. A., Decreased β -adrenoceptor-mediated vasodilation in aorta from aged rats: possible involvement of a stimulatory GTP-binding protein. European Journal of Pharmacology 1991 198 2-3 177 181 2-s2.0-0025828103
54. Mader S. L., Downing C. L., Amos-Landgraf J., Swebjka P., Age-related changes in G proteins in rat aorta. Journals of GerontologySeries A 1996 51 2 B111 B116 2-s2.0-0029993694 (Pubitemid 26088404)
55. Schutzer W. E., Watts V. J., Chapman J., Cumbay M. G., Neve K. A., Neve R. L., Mader S. L., Viral-mediated gene delivery of constitutively activated G α s alters vasoreactivity. Clinical and Experimental Pharmacology and Physiology 2000 27 1-2 9 13 2-s2.0-0033973793 10.1046/j.1440-1681.2000.03210.x (Pubitemid 30104084)
56. Chen J., DeVivo M., Dingus J., Harry A., Li J., Sui J., Carty D. J., Blank J. L., Exton J. H., Stoffel R. H., Inglese J., Lefkowitz R. J., Logothetis D. E., Hildebrandt J. D., Iyengar R., A region of adenylyl cyclase 2 critical for regulation by G protein βγ subunits. Science 1995 268 5214 1166 1169 2-s2.0-0029069790
57. Clapham D. E., Neer E. J., G protein beta gamma subunits. Annual Review of Pharmacology and Toxicology 1997 37 167 203
58. Schutzer W. E., Mader S. L., Age-related changes in adrenergic signaling: clinical and mechanistic implications. Ageing Research Reviews 2003 2 2 169 190 2-s2.0-0141611923 10.1016/S1568-1637(02)00063-6 (Pubitemid 37443911)
59. Mader S. L., Alley P. A., Age-related changes in adenylyl cyclase activity in rat aorta membranes. Mechanisms of Ageing & Development 1998 101 1-2 111 118 (Pubitemid 28165638)
60. Defer N., Best-Belpomme M., Hanoune J., Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. The American Journal of Physiology 2000 279 3 F400 F416 2-s2.0-0033835813
61. Zhang J., Sato M., Duzic E., Kubalak S. W., Lanier S. M., Webb J. G., Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. The American Journal of Physiology 1997 273 2 H971 H980 2-s2.0-0030820451
62. Schutzer W. E., Xue H., Reed J. F., Roullet J. B., Anderson S., Mader S. L., Angiotensin II enhances β -adrenergic receptor-mediated vasorelaxation in aorta from young but not old rats. The American Journal of Physiology 2000 279 6 H2807 H2814 2-s2.0-0034537377 (Pubitemid 32005869)
63. Schoeffter P., Stoclet J. C., Age-related differences in cyclic AMP metabolism and their consequences on relaxation induced by isoproterenol and phosphodiesterase inhibitors in rat isolated aorta. Mechanisms of Ageing and Development 1990 54 3 197 205 2-s2.0-0025326732 10.1016/0047-6374(90)90050-P (Pubitemid 20195831)
64. Miller C. L., Yan C., Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. Journal of Cardiovascular Translational Research 2010 3 5 507 515 2-s2.0-77958095148 10.1007/s12265-010-9203-9
65. Elvebak R. L., Eisenach J. H., Joyner M. J., Nicholson W. T., The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging. Clinical and Translational Science 2010 3 5 239 242 2-s2.0-78049311889 10.1111/j.1752-8062.2010.00232.x
66. Lohse M. J., Benovic J. L., Codina J., Cargon M. G., Lefkowitz R. J., β -Arrestin: a protein that regulates β -adrenergic receptor function. Science 1990 248 4962 1547 1550 2-s2.0-0025352299
67. Sohlemann P., Hekman M., Puzicha M., Buchen C., Lohse M. J., Binding of purified recombinant β -arrestin to guanine-nucleotide-binding-protein- coupled receptors. European Journal of Biochemistry 1995 232 2 464 470 2-s2.0-0029160575 10.1111/j.1432-1033.1995.tb20832.x
68. Fredericks Z. L., Pitcher J. A., Lefkowitz R. J., Identification of the G protein-coupled receptor kinases phosphorylation sites in the human β -adrenergic receptor. Journal of Biological Chemistry 1996 271 23 13796 13803 2-s2.0-0029884416
69. 1- adrenergic receptors in the failing human heart. Circulation 1993 87 2 454 463 2-s2.0-0027497584 (Pubitemid 23040915)
70. Huang H. M., Gibson G. E., Altered β -adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. Journal of Biological Chemistry 1993 268 20 14616 14621 2-s2.0-0027244664 (Pubitemid 23206596)
71. Schutzer W., Beard D., Reed J., Characterization of clonal vascular smooth muscle cell lines derived from young & old fischer 344 rats. In Vitro Cellular & Developmental BiologyAnimal 2011 47 7 445 450
72. Eckhart A. D., Ozaki T., Tevaearai H., Rockman H. A., Koch W. J., Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates β -adrenergic receptor signaling and increases resting blood pressure. Molecular Pharmacology 2002 61 4 749 758 2-s2.0-0036209075 10.1124/mol.61.4.749 (Pubitemid 34273154)
73. Gros R., Benovic J. L., Tan C. M., Feldman R. D., G-protein-coupled receptor kinase activity is increased in hypertension. Journal of Clinical Investigation 1997 99 9 2087 2093 2-s2.0-0031000256 (Pubitemid 27203764)
74. Nogues L., Salcedo A., Mayor F. Jr., Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2. Journal of Biological Chemistry 2011 286 2 1165 1173
75. Neubig R. R., Membrane organization in G-protein mechanisms. FASEB Journal 1994 8 12 939 946 2-s2.0-0027936892 (Pubitemid 24286857)
76. Smart E. J., Graf G. A., McNiven M. A., Sessa W. C., Engelman J. A., Scherer P. E., Okamoto T., Lisanti M. P., Caveolins, liquid-ordered domains, and signal transduction. Molecular and Cellular Biology 1999 19 11 7289 7304 2-s2.0-0032723268 (Pubitemid 29493393)
77. Oka N., Asai K., Kudej R. K., Edwards J. G., Toya Y., Schwencke G., Vatner D. E., Vatner S. F., Ishikawa Y., Downregulation of caveolin by chronic β -adrenergic receptor stimulation in mice. The American Journal of Physiology 1997 273 6 C1957 C1962 2-s2.0-0031417536
78. Schwencke C., Okumura S., Yamamoto M., Geng Y. J., Ishikawa Y., Colocalization of β -adrenergic receptors and caveolin within the plasma membrane. Journal of Cellular Biochemistry 1999 75 1 64 72 2-s2.0-0033213776 (Pubitemid 29402545)
79. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J. E., Hansen S. H., Nishimoto I., Lisanti M. P., Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. Journal of Biological Chemistry 1995 270 26 15693 15701 2-s2.0-0029075372 10.1074/jbc.270.26.15693
80. Schwencke C., Yamamoto M., Okumura S., Toya Y., Kim S. J., Ishikawa Y., Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae. Molecular Endocrinology 1999 13 7 1061 1070 2-s2.0-0033311162 (Pubitemid 30644295)
81. Ostrom R. S., Violin J. D., Coleman S., Insel P. A., Selective enhancement of β -adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Molecular Pharmacology 2000 57 5 1075 1079 2-s2.0-0034015701 (Pubitemid 30253394)
82. Toya Y., Schwencke C., Couet J., Lisanti M. P., Ishikawa Y., Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 1998 139 4 2025 2031 2-s2.0-0031733584 (Pubitemid 28513865)
83. Carman C. V., Lisanti M. P., Benovic J. L., Regulation of G-protein receptor kinases by caveolin. Journal of Biological Chemistry 1999 274 13 8858 8864 2-s2.0-0033605584 10.1074/jbc.274.13.8858 (Pubitemid 29164686)
84. Kawabe J., Grant B. S., Yamamoto M., Schwencke C., Okumura S., Ishikawa Y., Changes in caveolin subtype protein expression in aging rat organs. Molecular and Cellular Endocrinology 2001 176 1-2 91 95 2-s2.0-0035947398 10.1016/S0303-7207(01)00472-5 (Pubitemid 32454939)
85. Schutzer W. E., Reed J. F., Mader S. L., Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. The American Journal of Physiology 2005 288 5 H2457 H2464 2-s2.0-18044387220 10.1152/ajpheart.01090.2004 (Pubitemid 40604135)
86. Razani B., Lisanti M. P., Caveolin-deficient mice: insights into caveolar function and human diseases. Journal of Clinical Investigation 2001 108 11 1553 1561 2-s2.0-0035213597 10.1172/JCI200114611 (Pubitemid 33144862)
87. Razani B., Lisanti M. P., Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. The American Journal of Physiology 2001 281 4 C1241 C1250 2-s2.0-0034791112
88. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F. C., Schedl A., Hailer H., Kurzchalia T. V., Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001 293 5539 2449 2452 2-s2.0-0035964954 10.1126/science.1062688 (Pubitemid 32917325)
89. Winstel R., Freund S., Krasel C., Hoppe E., Lohse M. J., Protein kinase cross-talk: membrane targeting of the β -adrenergic receptor kinase by protein kinase C. Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 2105 2109 2-s2.0-0029877815 10.1073/pnas.93.5.2105 (Pubitemid 26079888)
90. Chuang T. T., Le Vine H., De Blasi A., Phosphorylation and activation of β -adrenergic receptor kinase by protein kinase C. Journal of Biological Chemistry 1995 270 31 18660 18665 2-s2.0-0029635377 10.1074/jbc.270.31.18660
91. Shih M., Malbon C. C., Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and β -adrenergic receptor kinase reveal distinctive cell-type- specific roles in agonist-induced desensitization. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12193 12197 2-s2.0-0028053755 10.1073/pnas.91.25.12193 (Pubitemid 24368631)
92. Kubalak S. W., Webb J. G., Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells. The American Journal of Physiology 1993 264 1 H86 H96 2-s2.0-0027408128 (Pubitemid 23059130)
93. Nabika T., Nara Y., Yamori Y., Angiotensin II and phorbol ester enhance isoproterenol- and vasoactive intestinal peptide (VIP)-induced cyclic AMP accumulation in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 1985 131 1 30 36 2-s2.0-0022195903 (Pubitemid 16251114)
94. Inoue T., Zaichuan M., Gillespie D. G., Dubey R. K., Jackson E. K., Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells. Journal of Pharmacology and Experimental Therapeutics 1999 288 3 1229 1234 2-s2.0-0344435221 (Pubitemid 29254163)
95. Mokkapatti R., Vyas S. J., Romero G. G., Mi Z., Inoue T., Dubey R. K., Gillespie D. G., Stout A. K., Jackson E. K., Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 1998 287 1 223 231 2-s2.0-0032462878 (Pubitemid 29140205)
96. Brizzolara-Gourdie A., Webb J. G., Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists. Journal of Pharmacology and Experimental Therapeutics 1997 281 1 354 359 2-s2.0-0030924647 (Pubitemid 27203088)
97. Jackson W. F., Ion channels and vascular tone. Hypertension 2000 35 1, part 2 173 178 2-s2.0-0033977162 (Pubitemid 30054169)
98. Fujii K., Onaka U., Goto K., Isao A., Fujishima M., Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats. Hypertension 1999 34 2 222 228 2-s2.0-0032842281 (Pubitemid 29409219)
99. Thorin E., Thorin-Trescases N., Vascular endothelial ageing, heartbeat after heartbeat. Cardiovascular Research 2009 84 1 24 32 2-s2.0-70449715297 10.1093/cvr/cvp236
100. Vanhoutte P. M., Endothelial adrenoceptors. Journal of Cardiovascular Pharmacology 2001 38 5 796 808 (Pubitemid 32983286)
101. Howell R. E., Albelda S. M., Daise M. L., Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells. Journal of Applied Physiology 1988 65 3 1251 1257
102. Brawley L., Shaw A. M., MacDonald A., β 1-, β 2- and atypical β -adrenoceptor-mediated relaxation in rat isolated aorta. The British Journal of Pharmacology 2000 129 4 637 644 2-s2.0-0034064712 (Pubitemid 30153846)
103. Kang K. B., van der Zypp A., Majewski H., Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta. Clinical and Experimental Pharmacology and Physiology 2007 34 1-2 95 101 (Pubitemid 46069592)
104. van der Zypp A., Kang K. B., Majewski H., Age-related involvement of the endothelium in β -adrenoceptor-mediated relaxation of rat aorta. European Journal of Pharmacology 2000 397 1 129 138 2-s2.0-0034717101 10.1016/S0014-2999(00)00193-X (Pubitemid 30323819)
105. Deisher T. A., Mankani S., Hoffman B. B., Role of cyclic AMP-dependent protein kinase in the diminished beta-adrenergic responsiveness of vascular smooth muscle with increasing age. Journal of Pharmacology and Experimental Therapeutics 1989 249 3 812 819 2-s2.0-0024409631 (Pubitemid 19166662)
106. Ishikawa M., Ouchi Y., Akishita M., Kozaki K., Toba K., Namiki A., Yamaguchi T., Ito H., Orimo H., Age-related decrease in the effect of parathyroid hormone-related protein on cytosolic free calcium level and tension in rat aortic smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 1995 351 5 517 522 2-s2.0-0028998752
107. Penela P., Murga C., Ribas C., Lafarga V., Mayor F., The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. The British Journal of Pharmacology 2010 160 4 821 832 2-s2.0-77952840083 10.1111/j.1476-5381.2010.00727.x
108. Fraeyman N., Van de Velde E., Van Ermen A., Bazan A., Vanderheyden P., Van Emmelo J., Vandekerckhove J., Effect of maturation and aging on β -adrenergic signal transduction in rat kidney and liver. Biochemical Pharmacology 2000 60 12 1787 1795 2-s2.0-0034672450 10.1016/S0006-2952(00)00493- 7
109. Rockman H. A., Koch W. J., Lefkowitz R. J., Seven-transmembrane-spanning receptors and heart function. Nature 2002 415 6868 206 212 2-s2.0-0037050009 10.1038/415206a (Pubitemid 34059526)
110. Preuss J. M., Rigby P. J., Goldie R. G., The influence of animal age on β -adrenoceptor density and function in tracheal airway smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 1999 360 2 171 178 2-s2.0-0032824143 10.1007/s002109900051 (Pubitemid 29420022)
111. Sastre M., Guimon J., Garcia-Sevilla J. A., Relationships between beta- and alpha2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide. Brain Research 2001 892 2 242 255 (Pubitemid 32299953)